The mission of the Euratom Supply Agency is
to maintain regular and equitable supply of nuclear materials
(ores, source material and special fissile material)
for all users in the European Atomic Energy Community.
The strategic objective is
the security of supply of nuclear materials, particularly nuclear fuel,
for power and non-power uses,
by means of the common supply policy.
10th anniversary of the European Observatory on the Supply of Medical Radioisotopes
29th June 2022 marked the 10th anniversary of the European Observatory on the Supply of Medical Radioisotopes.
On this occasion, Mr. Bartosz Arłukowicz, MEP, European Parliament, delivered a speech on Outcomes of the Special Committee on Beating Cancer (BECA) report.
REPowerEU Plan calls for diversification in nuclear fuel cycle
On 18 May 2022, the Commission adopted the REPowerEU plan, aimed at rapidly reducing EU dependence on Russian fossil fuels by fast forwarding the clean transition and joining forces to achieve a more resilient energy system and a true Energy Union.
It highlights the importance of a coordinated action to reduce dependence on Russian nuclear materials and fuel cycle services.
ESA Advisory Committee meeting took place on 12 May 2022
The meeting on 12 May 2022 was the first in person meeting of the Advisory Committee since the 60th anniversary of the continued operations of the Euratom Supply Agency.
On this occasion, the Commissioner for Energy, Kadri Simson delivered a key note speech via a video-link.
The Rules of the Euratom Supply Agency enter into force on 1 July 2021
The Rules lay down the manner in which ESA - responsible for a regular and equitable supply of nuclear materials for all users within the Community - is to balance demand against supply of ores, source materials and special fissile materials.
See the press release.
European Observatory on the Supply of Medical Radioisotopes held plenary meeting
Nine years after its creation in 2012, the European Observatory on the Supply of Medical Radioisotopes held its 17th plenary e-meeting on 29 June.
The Observatory aims to assess, monitor and support the EU supply of medical radioisotopes with the emphasis on the most vital Molybdenum-99/Technetium-99m (Mo-99/Tc-99m) radioisotope, used in 80% of all nuclear medicine diagnostic procedures.
See the full article.